Source: Annual Congress 2006 - Community-acquired pneumonia: risk factors and treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. V. Rubanik, N. L. Shaporova, V. I. Trofimov (Saint-Petersburg, Russian Federation). The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course. Eur Respir J 2006; 28: Suppl. 50, 2096

Member's Comments

No comment yet.

Related content which might interest you: The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Risk factors for early onset severe community-acquired pneumonia complications Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 The tobacco-smoking influence on the community-acquired pneumonia course Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006 The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1214 Year: 2014 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1213 Year: 2014 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Source: Eur Respir J 2012; 39: 187-196 Year: 2012 Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Source: Eur Respir J 2011; 39: 187-196 Year: 2012 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly Source: Eur Respir J 2013; 41: 923-928 Year: 2013 Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer Source: Eur Respir Rev 2008; 17: 83-85 Year: 2008